Myasthenia Gravis Outcomes After Use of Statins and Other Contraindicated Treatments: Results From the French National Insurance Database [0.03%]
免疫抑制剂禁忌证患者使用他汀类和其他药物后重症肌无力预后的全国调查研究
Guilhem Solé,Jean Philippe Camdessanché,Shahram Attarian et al.
Guilhem Solé et al.
Background: Clinical guidelines for treating myasthenia gravis (MG) recommend avoiding certain therapies because of a risk of exacerbating MG. We evaluated use of statins and other classically contraindicated therapies an...
Observational Study
European journal of neurology. 2026 Jan;33(1):e70504. DOI:10.1111/ene.70504 2026
Comment on "Variation in Repeated Handgrip Strength Testing Indicates Submaximal Force Production in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" [0.03%]
对肌痛性脑脊髓炎/慢性疲劳综合征患者反复握力测试变化表示亚最大力量产生的影响评论
Felix Steinkirchner,Viktoria Kimmerling,Christina Kaufmann et al.
Felix Steinkirchner et al.
Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis? [0.03%]
不同医师间的一致性对多发性硬化诊断标准的分类有影响吗？
Nima Mahmoudi,Julius Renne,Franz Felix Konen et al.
Nima Mahmoudi et al.
Background: Studies on interrater agreement in MRI analysis for patients experiencing a first clinical episode suggestive of multiple sclerosis (MS) are limited and outdated. This study aimed to evaluate interrater agreem...
Borrelia Infections Under B Cell-Depleting Therapies: A Systematic Review of Diagnostic Challenges and Outcomes With Special Focus on Neurological Forms [0.03%]
布氏菌病在B细胞耗竭疗法下的感染：以神经系统形式为重点的诊断挑战和治疗结果的系统性回顾
Emilie Cardot-Martin,Jean Baptiste Chanson,Cédric Lenormand et al.
Emilie Cardot-Martin et al.
Context: B-cell-depleting therapies such as rituximab and newer anti-CD20 agents may impair humoral immune responses and reduce the reliability of serological testing. This systematic review aims to summarize reported cas...
Diagnostic Yield and Genotype-Phenotype Correlations of Clinical Exome Sequencing in Hereditary Spastic Paraparesis: Experience From Eastern Spain [0.03%]
东方西班牙遗传性痉挛性轻偏瘫临床外显子组测序的诊断率及基因型与表型相关性：一项回顾性研究
Lidón Carretero-Vilarroig,Rafael Sivera,Raquel Baviera et al.
Lidón Carretero-Vilarroig et al.
Background: Hereditary spastic paraparesis (HSP) encompasses a genetically and clinically heterogeneous group of neurodegenerative disorders, primarily characterized by progressive lower limb spasticity and weakness of th...
Moving Beyond Population-Level Analyses to Characterize Individual Heterogeneity in CMAP Responses Would Enhance the Assessment of Its Clinical Utility [0.03%]
从人口水平分析转向表征CMAP反应的个体异质性以增强其临床应用价值的评估方法将会有所裨益
Yujie Zhang,Jia Hu,Yuting Pu et al.
Yujie Zhang et al.
Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic Review [0.03%]
深脑刺激治疗单基因扭转痉挛的有效性：一项系统综述研究
Elisabetta Indelicato,Beatriz Carmona-Hidalgo,Javier Quintero et al.
Elisabetta Indelicato et al.
Background: Deep brain stimulation (DBS) is an essential treatment option for disabling segmental or generalized dystonia. An underlying monogenic etiology is increasingly recognized as an important predictor of DBS outco...
The Use of Combined Fundus Photography and Perimetry for the Assessment of Patients Referred for Intracranial Hypertension or Follow-Up of the Diagnosis in a Tertiary Headache Center [0.03%]
三叉神经痛中心用于颅内高压患者转诊或诊断后随访的联合眼底摄影和视野检查的使用价值评估
Zainab Rissan,Nadja Skadkær Hansen,Vlasta Vukovic-Cvetkovic et al.
Zainab Rissan et al.
Objectives: Idiopathic intracranial hypertension (IIH) is characterized by increased intracranial pressure and papilledema. If left untreated, it can lead to vision loss, and, timely detection of papilledema is of paramou...
Co-Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature [0.03%]
重症肌无力和面肩肱型肌营养不良并存的病例系列及文献复习
Giulia Tammam,Luisa Villa,Richard J L F Lemmers et al.
Giulia Tammam et al.
Background: Facioscapulohumeral dystrophy (FSHD) and Myasthenia Gravis (MG) are well-known rare neuromuscular diseases of respectively genetic and acquired origin. Among muscular dystrophies, the co-occurrence of MG with ...
Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy" [0.03%]
关于《Editorial Letter：“重新确认谨慎态度——在 moyamoya 血管病中 CGRP 相关疗法不可接受的血管收缩风险》的回复
Nicola Rifino,Anne Hege Aamodt,Markus Wiedmann et al.
Nicola Rifino et al.